Cargando…

Incidence and risk factors of venous thromboembolism (VTD) in patients with amyloidosis

BACKGROUND: Coagulation problems in amyloidosis are historically associated with bleeding tendencies (mostly Factor X abnormalities). Increased clotting was observed in isolated cases diagnosed with low-grade disseminated intravascular coagulation (DIC). Problem of venous thromboembolic disaease (VT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Srkalovic, Gordan, Cameron, Marte G, Deitcher, Steven R, Kattke-Marchant, Kandice, Hussein, Mohamad A
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1232862/ https://www.ncbi.nlm.nih.gov/pubmed/16138931 http://dx.doi.org/10.1186/1477-7800-2-17

Ejemplares similares

Comparative efficacy and safety of bortezomib, thalidomide, and dexamethasone (VTd) without and with daratumumab (D‐VTd) in CASSIOPEIA versus VTd in PETHEMA/GEM in transplant‐eligible patients with newly diagnosed multiple myeloma, using propensity score matching
por: Moreau, Philippe, et al.
Publicado: (2020)

Partial Response at Completion of Bortezomib-Thalidomide-Dexamethasone (VTd) Induction Regimen Upfront in Multiple Myeloma Does Not Preclude Response to VTd in Consolidation
por: Fouquet, Guillemette, et al.
Publicado: (2014)

Benefits of additional cycles of bortezomib/thalidomide/dexamethasone (VTD) induction therapy compared to four cycles of VTD for newly diagnosed multiple myeloma
por: Lee, Yoo Jin, et al.
Publicado: (2019)

VTd-PACE and VTd-PACE-like regimens are effective salvage therapies in difficult-to-treat relapsed/refractory multiple myeloma: a single-center experience
por: Ghandili, Susanne, et al.
Publicado: (2022)

Hematocrit and incidence of venous thromboembolism
por: Folsom, Aaron R., et al.
Publicado: (2020)

Venous thromboembolism in critically ill patients: incidence and risk factors
por: Al-Qahtani, S, et al.
Publicado: (2007)

The Cumulative Incidence and Risk Factors of Recurrent Venous Thromboembolism in the Elderly
por: Aleidan, Fahad A S
Publicado: (2020)

Incidence and Risk Factors of Recurrent Venous Thromboembolism after Pulmonary Embolism
por: Hwang, Hun-Gyu, et al.
Publicado: (2019)

Incidence and risk factors of perioperative venous thromboembolism in patients with cervical cancer
por: Zhao, Hongle, et al.
Publicado: (2022)

P21 EFFECTIVENESS AND SAFETY OF DELAYED BORTEZOMIB, THALIDOMIDE AND DEXAMETHASONE (VTD) REGIMEN
por: Del Fabro, V., et al.
Publicado: (2023)

Incident thrombus location and predicting risk of recurrent venous thromboembolism
por: Lidstrom, Sara C., et al.
Publicado: (2022)

Matching‐adjusted indirect comparison of efficacy and safety of bortezomib, thalidomide, and dexamethasone (VTd) as per label compared with modified VTd dosing schedules in patients with newly diagnosed multiple myeloma who are transplant eligible
por: Sonneveld, Pieter, et al.
Publicado: (2020)

Incidence, risk factors and outcome of venous thromboembolism in critically ill obstetric patients
por: Kaddour, C, et al.
Publicado: (2008)

Incidence and risk factors for venous thromboembolism in patients with pretreated advanced pancreatic carcinoma
por: Kondo, Shunsuke, et al.
Publicado: (2018)

Incidence of and Risk Factors Associated with Postoperative Venous Thromboembolism in Hysterectomy for Benign Indications
por: Duyar, S., et al.
Publicado: (2020)

Incidence and Risk Factors for Venous Thromboembolism in Female Patients Undergoing Breast Surgery
por: Londero, Ambrogio P., et al.
Publicado: (2022)

Incidence and risk factors of clinically important venous thromboembolism in tibial plateau fractures
por: Wang, Pengfei, et al.
Publicado: (2022)

Venous thromboembolism and sarcoidosis: co-incidence or coexistence?
por: Goljan-Geremek, Anna, et al.
Publicado: (2016)

Incidence of venous thromboembolism in japanese trauma population
por: Miki, R, et al.
Publicado: (2015)

Resting heart rate and incidence of venous thromboembolism
por: Folsom, Aaron R., et al.
Publicado: (2019)

Metabolites Associated With the Risk of Incident Venous Thromboembolism: A Metabolomic Analysis
por: Jiang, Xia, et al.
Publicado: (2018)

Hand grip strength and risk of incident venous thromboembolism: The Tromsø study
por: Leknessund, Oda G. R., et al.
Publicado: (2022)

Risk and Risk Factors Associated With Recurrent Venous Thromboembolism Following Surgery in Patients With History of Venous Thromboembolism
por: Nemeth, Banne, et al.
Publicado: (2019)

Incidence and Risk Factors of Venous Thromboembolism in Patients After Transurethral Resection of the Prostate (TURP)
por: Zheng, Zhihuan, et al.
Publicado: (2022)

Venous thromboembolism in children undergoing surgery: incidence, risk factors and related adverse events
por: Mets, Elbert Johann, et al.
Publicado: (2020)

Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry stomach cancer subcohort
por: Yoshikawa, Takaki, et al.
Publicado: (2023)

Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort
por: Okusaka, Takuji, et al.
Publicado: (2023)

Venous thromboembolism and cancer risk
por: Sandén, Per, et al.
Publicado: (2016)

Psychometric Characteristics of Different Versions of Vocal Tract Discomfort (VTD) Scale: A Systematic Review
por: Aghaei, Fateme, et al.
Publicado: (2022)

Cardiovascular Risk Factors Associated With Venous Thromboembolism
por: Gregson, John, et al.
Publicado: (2019)

Incidence of venous thromboembolism in Korea from 2009 to 2013
por: Hong, Junshik, et al.
Publicado: (2018)

Incidence of venous thromboembolism in hospitalized patients with COVID‐19
por: Middeldorp, Saskia, et al.
Publicado: (2020)

Incidence of Venous Thromboembolism in Hospitalized Patients with COVID-19
por: Middeldorp, S., et al.
Publicado: (2021)

Incidence of venous thromboembolism following head and neck surgery
por: Albertsen, Ida E., et al.
Publicado: (2023)

Venous ligation versus venous repair: does the procedure impact venous thromboembolism risk?
por: Farrell, Michael Steven, et al.
Publicado: (2021)

Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)
por: Freeman, Dilys J, et al.
Publicado: (2011)

Galectin‐3 and venous thromboembolism incidence: the Atherosclerosis Risk in Communities (ARIC) Study
por: Fashanu, Oluwaseun E., et al.
Publicado: (2017)

Incidence and risk factors of chronic thromboembolic pulmonary hypertension following venous thromboembolism, a population-based cohort study in England
por: Martinez, C., et al.
Publicado: (2018)

Risk of venous thromboembolism in Chinese pregnant women: Hong Kong venous thromboembolism study
por: Huang, Duo, et al.
Publicado: (2019)

Incidence of Venous Thromboembolism, Risk Factors and Prophylaxis in Hospitalized Patients in the South West Region of Cameroon
por: Nkoke, Clovis, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mlem0d0mchar4ogchen31trs5i